LONG-TERM TREATMENT WITH SARILUMAB PLUS CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (CSDMARDS): POOLED SAFETY AND EFFICACY WITH OVER 4 YEARS' TREATMENT

被引：0

作者：

van Hoogstraten, Hubert ^{[1
]}

St John, Gregory ^{[2
]}

Thangavelu, Karthinathan ^{[3
]}

Jose Gomez-Reino, Juan ^{[4
]}

Antonio Maldonado-Cocco, Jose ^{[5
]}

Carlos Salazar, Juan ^{[6
]}

Huizinga, Thomas ^{[7
]}

Wilson, Elaine ^{[8
]}

Burmester, Gerd R. ^{[9
]}

机构：

[1] Sanofi Genzyme, Global Med Affairs, Bridgewater, NJ USA

[2] Regeneron Pharmaceut Inc, Med Affairs, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[3] Sanofi Genzyme, Biostat, Bridgewater, NJ USA

[4] Complejo Hosp Univ Santiago Compostela, Rheumatol, Santiago, Spain

[5] Buenos Aires Univ, Sch Med, Buenos Aires, DF, Argentina

[6] Riesgo Fractura SA CAYRE, Rheumatol, Bogota, Colombia

[7] Leiden Univ, Med Ctr, Rheumatol, Leiden, Netherlands

[8] Sanofi Genzyme, Rheumatol, Oxford, England

[9] Charite Univ Med Berlin, Rheumatol & Clin Immunol, Berlin, Germany

来源：

RHEUMATOLOGY | 2019年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

080

引用

页码：74 / 75

页数：2

共 50 条

[1] Long-Term Treatment with Sarilumab Plus Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs): Pooled Safety and Efficacy with over 4 Years' Treatment
Genovese, Mark C.
van Hoogstraten, Hubert
St John, Gregory
Dong, Qunming
Jose Gomez-Reino, Juan
Maldonado-Cocco, Jose A.
Carlos Salazar, Juan
Huizinga, Tom W. J.
Burmester, Gerd R.
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[2] Long-Term Safety with Sarilumab Plus Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) and Sarilumab Monotherapy in Rheumatoid Arthritis (RA): An Integrated Analysis with 9,000 Patient-Years (Pt-Yrs) of Follow-up
Fleischmann, Roy
Lin, Yong
St John, Gregory
van der Heijcle, Desiree
Qiu, Chunfu
Jose Gomez-Reino, Juan
Maldonado-Cocco, Jose A.
Stanislav, Marina
Seriolo, Bruno
Burmester, Gerd R.
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[3] LONG-TERM SAFETY WITH SARILUMAB PLUS CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AND SARILUMAB MONOTHERAPY IN RHEUMATOID ARTHRITIS: AN INTEGRATED ANALYSIS WITH 9,000 PATIENT-YEARS OF FOLLOW-UP
Fleischmann, Roy
Lin, Yong
St John, Gregory
van der Heijde, Desiree
Qiu, Chunfu
Jose Gomez-Reino, Juan
Antonio Maldonado-Cocco, Jose
Stanislav, Marina
Seriolo, Bruno
Burmester, Gerd Ruediger
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1130 - 1131
[4] LONG-TERM SAFETY WITH SARILUMAB PLUS CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AND SARILUMAB MONOTHERAPY IN RHEUMATOID ARTHRITIS: AN INTEGRATED ANALYSIS WITH 9,000 PATIENT-YEARS OF FOLLOW-UP
Fleischmann, Roy
Lin, Yong
St John, Gregory
van der Heijde, Desiree
Qiu, Chunfu
Carlos Gomez-Reino, Juan
Antonio Maldonado-Cocco, Jose
Stanislav, Marina
Seriolo, Bruno
Tranter, Lesley
Burmester, Gerd R.
[J]. RHEUMATOLOGY, 2019, 58
[5] WITHDRAWAL OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN THE SARILUMAB OPEN-LABEL EXTEND STUDY: EFFICACY AND SAFETY ANALYSIS
Curtis, Jeffrey R.
Lin, Yong
Thangavelu, Karthinathan
Stanislav, Marina
St John, Gregory
Gomez-Centeno, Antonio
Selmi, Carlo
Huizinga, Thomas
Antonio Maldonado-Cocco, Jose
Bukhari, Marwan
Buttgereit, Frank
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 702 - 703
[6] Withdrawal of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Sarilumab Open-Label EXTEND Study: Efficacy and Safety Analysis
Curtis, Jeffrey
Lin, Yong
Thangavelu, Karthinathan
Stanislav, Marina
St John, Gregory
Gomez-Centeno, Antonio
Selmi, Carlo
Huizinga, Thomas
Antonio Maldonado-Cocco, Jose
Bukhari, Marwan
Buttgereit, Frank
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[7] Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
Ernest Choy
Nick Freemantle
Clare Proudfoot
Chieh-I Chen
Laurence Pollissard
Andreas Kuznik
Hubert van Hoogstraten
Erin Mangan
Paulo Carita
Thi-Minh-Thao Huynh
[J]. Advances in Therapy, 2019, 36 : 817 - 827
[8] Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
Choy, Ernest
Freemantle, Nick
Proudfoot, Clare
Chen, Chieh-I
Pollissard, Laurence
Kuznik, Andreas
van Hoogstraten, Hubert
Mangan, Erin
Carita, Paulo
Thi-Minh-Thao Huynh
[J]. ADVANCES IN THERAPY, 2019, 36 (04) : 817 - 827
[9] Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids
van Vollenhoven, Ronald
Helt, Cameron
Arora, Vipin
Zhong, Jinglin
Correia, Ana Pinto
de la Torre, Inma
Muram, David
[J]. RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 525 - 536
[10] Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids
Ronald van Vollenhoven
Cameron Helt
Vipin Arora
Jinglin Zhong
Ana Pinto Correia
Inma de la Torre
David Muram
[J]. Rheumatology and Therapy, 2018, 5 : 525 - 536

← 1 2 3 4 5 →